Odonate Therapeutics Net Tangible Assets

Odonate Therapeutics (ODT) currently reports a net tangible assets of $71M as of September 2021. That compares with $170M in the prior-year period — down 56.9% year over year. Use the charts on this page to explore Odonate Therapeutics's net tangible assets history and peer comparisons.

Odonate Therapeutics's net tangible assets decreased from $170M to $71M — a 56.9% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Odonate Therapeutics reported $71M in net tangible assets as of September 2021. That compares with $170M in the prior-year period — down 56.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $71M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Odonate Therapeutics, and consider following ODT for alerts when major investors trade the stock.

Odonate Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $71M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ODT with unrelated industries.